We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+11.79%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$534M
AUM Growth
-$21.9M
Cap. Flow
-$79.4M
Cap. Flow %
-14.86%
Top 10 Hldgs %
43.67%
Holding
341
New
6
Increased
22
Reduced
97
Closed
12

Top Buys

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$1M
2
TDOC icon
Teladoc Health
TDOC
+$518K
3
CCXI
ChemoCentryx, Inc.
CCXI
+$307K
4
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$200K
5
EGIO
Edgio, Inc. Common Stock
EGIO
+$179K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.63M
2
MSFT icon
Microsoft
MSFT
+$8.52M
3
AMZN icon
Amazon
AMZN
+$7.33M
4
V icon
Visa
V
+$3.3M
5
META icon
Meta Platforms (Facebook)
META
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 32%
2 Consumer Discretionary 14.6%
3 Healthcare 14.58%
4 Financials 11.75%
5 Communication Services 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
176
Chevron
CVX
$385B
$188K 0.04%
2,615
– –
MIME
177
DELISTED
Mimecast Limited
MIME
$185K 0.03%
3,952
-1,396
-26% -$63.3K
ALLK
178
DELISTED
Allakos
ALLK
$183K 0.03%
2,242
– –
ABT icon
179
Abbott
ABT
$185B
$181K 0.03%
1,663
– –
KLAC icon
180
KLA
KLAC
$239B
$179K 0.03%
9,240
– –
MMM icon
181
3M
MMM
$91.4B
$175K 0.03%
1,306
– –
CVCO icon
182
Cavco Industries
CVCO
$4.2B
$171K 0.03%
948
– –
ESE icon
183
ESCO Technologies
ESE
$8.24B
$170K 0.03%
2,104
– –
FATE icon
184
Fate Therapeutics
FATE
$291M
$169K 0.03%
4,230
+1,436
+51% +$50.1K
PAYX icon
185
Paychex
PAYX
$41.9B
$168K 0.03%
2,108
– –
DUK icon
186
Duke Energy
DUK
$96.9B
$167K 0.03%
1,886
– –
KPTI icon
187
Karyopharm Therapeutics
KPTI
$44.6M
$166K 0.03%
759
+521
+219% +$127K
ORCL icon
188
Oracle
ORCL
$409B
$166K 0.03%
2,783
– –
PZZA icon
189
Papa John's
PZZA
$1.02B
$166K 0.03%
2,020
– –
EGIO
190
DELISTED
Edgio, Inc. Common Stock
EGIO
$165K 0.03%
+716
New +$179K
CAT icon
191
Caterpillar
CAT
$382B
$160K 0.03%
1,076
– –
UPS icon
192
United Parcel Service
UPS
$90.8B
$160K 0.03%
958
– –
MDGL icon
193
Madrigal Pharmaceuticals
MDGL
$11.1B
$153K 0.03%
1,291
– –
FFIN icon
194
First Financial Bankshares
FFIN
$5.08B
$149K 0.03%
5,299
-4,678
-47% -$139K
VFC icon
195
VF Corp
VFC
$5.87B
$149K 0.03%
2,127
– –
XOM icon
196
ExxonMobil
XOM
$643B
$149K 0.03%
4,345
– –
RPAY icon
197
Repay Holdings
RPAY
$343M
$143K 0.03%
+6,076
New +$147K
IEUS icon
198
iShares MSCI Europe Small-Cap ETF
IEUS
$181M
$142K 0.03%
2,753
– –
AKRO
199
DELISTED
Akero Therapeutics
AKRO
$138K 0.03%
4,482
+1,684
+60% +$58.9K
SBUX icon
200
Starbucks
SBUX
$118B
$138K 0.03%
1,604
+260
+19% +$20.7K
6 7
8
9 10

Similar funds

NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Silvant Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Silvant Capital Management held 341 positions worth $534M, down 3.9% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Silvant Capital Management withdrew a net $79.4M in Q3 2020, closing 12 positions and reducing 97 holdings. Its most notable exit was HealthEquity, an estimated $390K position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Silvant Capital Management opened a new position in Akamai worth $998K.

  • Silvant Capital Management's largest Q3 2020 buy was Akamai: 9,024 shares worth $998K.
  • Silvant Capital Management added most to Teladoc Health in Q3 2020, an estimated $518K increase.
  • Silvant Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $8.63M.
  • Silvant Capital Management fully exited HealthEquity in Q3 2020, selling an estimated $390K.
  • Silvant Capital Management's ten largest holdings make up 44% of its $534M portfolio in Q3 2020.
  • Silvant Capital Management opened 6 new positions and closed 12 in Q3 2020.
  • Silvant Capital Management's portfolio value fell 3.9% quarter-over-quarter to $534M.

Based on Silvant Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.